Inventor
VENKATESAN ARANAPAKAM MUDUMBAI
US25 patents
⚠️ This page may combine multiple inventors who share the name “VENKATESAN ARANAPAKAM MUDUMBAI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMERICAN CYANAMID CO
7 patentsUS5929097AJul 27, 1999
Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
AMERICAN CYANAMID CO78 citations95
US6197791B1Mar 6, 2001
N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
AMERICAN CYANAMID CO52 citations94
US6441023B1Aug 27, 2002
N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
AMERICAN CYANAMID CO14 citations91
US6172057B1Jan 9, 2001
N-Hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
AMERICAN CYANAMID CO36 citations88
US6462073B2Oct 8, 2002
N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
AMERICAN CYANAMID CO4 citations74
US6342508B1Jan 29, 2002
N-hydroxy-2-(Alkyl,Aryl or Heteroaryl sulfanyl, sulfinyl or sulfonyl) 3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
AMERICAN CYANAMID CO10 citations72
US6288086B1Sep 11, 2001
N-hydroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
AMERICAN CYANAMID CO3 citations63
WYETH LLC
7 patentsUS8748421B2Jun 10, 2014
Triazine compounds as P13 kinase and MTOR inhibitors
WYETH LLC11 citations92
US8039469B2Oct 18, 2011
Triazine compounds as PI3 kinase and mTOR inhibitors
WYETH LLC15 citations91
US8859542B2Oct 14, 2014
Triazine compounds as PI3 kinase and mTOR inhibitors
WYETH LLC9 citations83
US9174963B2Nov 3, 2015
Triazine compounds as PI3 kinase and MTOR inhibitors
WYETH LLC5 citations82
US10022381B2Jul 17, 2018
Triazine compounds as PI3 kinase and mTOR inhibitors
WYETH LLC5 citations72
US7691842B2Apr 6, 2010
Tricyclic 6-alkylidene-penems as β-lactamase inhibitors
WYETH LLC2 citations62
US7812014B2Oct 12, 2010
Bicyclic 6-alkylidene-penems as β-lactamase inhibitors
WYETH LLC0 citations50
WYETH CORP
6 patentsUS7018997B2Mar 28, 2006
Tricyclic 6-alkylidene-penems as β-lactamase inhibitors
WYETH CORP12 citations83
US7112582B2Sep 26, 2006
Bicyclic 6-alkylidene-penems as β-lactamase inhibitors
WYETH CORP16 citations82
US7148235B2Dec 12, 2006
Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression
WYETH CORP2 citations61
US7276603B2Oct 2, 2007
Benzofuranyl-and benzothienyl-piperazinyl quinolines and methods of their use
WYETH CORP5 citations60
US7235569B2Jun 26, 2007
Piperidinyl indole and tetrohydropyridinyl indole derivatives and method of their use
WYETH CORP4 citations60
US7229983B2Jun 12, 2007
4-substituted or unsubstituted-7-hydro-1,4-thiazepine-7-[bicyclic or tricyclic heteroaryl] substituted-3,6-dicarboxylic acid derivatives as β-lactamase inhibitors
WYETH CORP0 citations41